Revised SPC: Asacol (mesalazine) preparations

SPC now notes that severe cutaneous adverse reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with mesalazine (frequency unknown). It should be discontinued, at the first appearance of signs and symptoms of severe skin reactions.

Source:

electronic Medicines compendium